200 related articles for article (PubMed ID: 29982462)
1. Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles.
Ravel-Chapuis A; Al-Rewashdy A; Bélanger G; Jasmin BJ
Hum Mol Genet; 2018 Oct; 27(19):3361-3376. PubMed ID: 29982462
[TBL] [Abstract][Full Text] [Related]
2. Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.
Brockhoff M; Rion N; Chojnowska K; Wiktorowicz T; Eickhorst C; Erne B; Frank S; Angelini C; Furling D; Rüegg MA; Sinnreich M; Castets P
J Clin Invest; 2017 Feb; 127(2):549-563. PubMed ID: 28067669
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients.
Ravel-Chapuis A; Duchesne E; Jasmin BJ
J Physiol; 2022 Jul; 600(14):3249-3264. PubMed ID: 35695045
[TBL] [Abstract][Full Text] [Related]
4. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features.
Crawford Parks TE; Marcellus KA; Péladeau C; Jasmin BJ; Ravel-Chapuis A
Hum Mol Genet; 2020 Aug; 29(13):2185-2199. PubMed ID: 32504084
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner.
Misquitta NS; Ravel-Chapuis A; Jasmin BJ
Hum Mol Genet; 2023 Jan; 32(4):551-566. PubMed ID: 36048859
[TBL] [Abstract][Full Text] [Related]
7. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1.
Morriss GR; Rajapakshe K; Huang S; Coarfa C; Cooper TA
Hum Mol Genet; 2018 Aug; 27(16):2789-2804. PubMed ID: 29771332
[TBL] [Abstract][Full Text] [Related]
9. Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier.
Bondy-Chorney E; Crawford Parks TE; Ravel-Chapuis A; Klinck R; Rocheleau L; Pelchat M; Chabot B; Jasmin BJ; Côté J
PLoS Genet; 2016 Jan; 12(1):e1005827. PubMed ID: 26824521
[TBL] [Abstract][Full Text] [Related]
10. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
11. Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin-NFAT signaling in skeletal muscle of DM1 mice.
Ravel-Chapuis A; Bélanger G; Côté J; Michel RN; Jasmin BJ
Hum Mol Genet; 2017 Jun; 26(12):2192-2206. PubMed ID: 28369518
[TBL] [Abstract][Full Text] [Related]
12. Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.
Wang M; Weng WC; Stock L; Lindquist D; Martinez A; Gourdon G; Timchenko N; Snape M; Timchenko L
Mol Cell Biol; 2019 Nov; 39(21):. PubMed ID: 31383751
[TBL] [Abstract][Full Text] [Related]
13. Effect of exercise intensity and AICAR on isoform-specific expressions of murine skeletal muscle PGC-1α mRNA: a role of β₂-adrenergic receptor activation.
Tadaishi M; Miura S; Kai Y; Kawasaki E; Koshinaka K; Kawanaka K; Nagata J; Oishi Y; Ezaki O
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E341-9. PubMed ID: 21098736
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
[TBL] [Abstract][Full Text] [Related]
15. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
16. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
17. Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy.
Chen G; Masuda A; Konishi H; Ohkawara B; Ito M; Kinoshita M; Kiyama H; Matsuura T; Ohno K
Sci Rep; 2016 Apr; 6():25317. PubMed ID: 27126921
[TBL] [Abstract][Full Text] [Related]
18. Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.
Bargiela A; Sabater-Arcis M; Espinosa-Espinosa J; Zulaica M; Lopez de Munain A; Artero R
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25203-25213. PubMed ID: 31754023
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing.
Ravel-Chapuis A; Bélanger G; Yadava RS; Mahadevan MS; DesGroseillers L; Côté J; Jasmin BJ
J Cell Biol; 2012 Mar; 196(6):699-712. PubMed ID: 22431750
[TBL] [Abstract][Full Text] [Related]
20. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
Dastidar S; Ardui S; Singh K; Majumdar D; Nair N; Fu Y; Reyon D; Samara E; Gerli MFM; Klein AF; De Schrijver W; Tipanee J; Seneca S; Tulalamba W; Wang H; Chai YC; In't Veld P; Furling D; Tedesco FS; Vermeesch JR; Joung JK; Chuah MK; VandenDriessche T
Nucleic Acids Res; 2018 Sep; 46(16):8275-8298. PubMed ID: 29947794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
